These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32027622)

  • 1. BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.
    Ren Y; Huang SH; Patel S; Alberto WDC; Magat D; Ahimovic D; Macedo AB; Durga R; Chan D; Zale E; Mota TM; Truong R; Rohwetter T; McCann CD; Kovacs CM; Benko E; Wimpelberg A; Cannon C; Hardy WD; Bosque A; Bollard CM; Jones RB
    J Clin Invest; 2020 May; 130(5):2542-2559. PubMed ID: 32027622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective BCL-X
    Ren Y; Huang SH; Macedo AB; Ward AR; Alberto WDC; Klevorn T; Leyre L; Copertino DC; Mota TM; Chan D; Truong R; Rohwetter T; Zumbo P; Dündar F; Betel D; Kovacs C; Benko E; Bosque A; Jones RB
    J Virol; 2021 Jul; 95(15):e0242520. PubMed ID: 33980597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
    Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
    J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.
    Palermo E; Acchioni C; Di Carlo D; Zevini A; Muscolini M; Ferrari M; Castiello L; Virtuoso S; Borsetti A; Antonelli G; Turriziani O; Sgarbanti M; Hiscott J
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4
    Kulpa DA; Talla A; Brehm JH; Ribeiro SP; Yuan S; Bebin-Blackwell AG; Miller M; Barnard R; Deeks SG; Hazuda D; Chomont N; Sékaly RP
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
    Ruiz A; Blanch-Lombarte O; Jimenez-Moyano E; Ouchi D; Mothe B; Peña R; Galvez C; Genescà M; Martinez-Picado J; Goulder P; Barnard R; Howell B; Clotet B; Prado JG
    Front Immunol; 2018; 9():3162. PubMed ID: 30723480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.
    Sloan DD; Lam CY; Irrinki A; Liu L; Tsai A; Pace CS; Kaur J; Murry JP; Balakrishnan M; Moore PA; Johnson S; Nordstrom JL; Cihlar T; Koenig S
    PLoS Pathog; 2015; 11(11):e1005233. PubMed ID: 26539983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.
    Cummins NW; Sainski AM; Dai H; Natesampillai S; Pang YP; Bren GD; de Araujo Correia MCM; Sampath R; Rizza SA; O'Brien D; Yao JD; Kaufmann SH; Badley AD
    J Virol; 2016 Apr; 90(8):4032-4048. PubMed ID: 26842479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.
    Jones RB; Mueller S; O'Connor R; Rimpel K; Sloan DD; Karel D; Wong HC; Jeng EK; Thomas AS; Whitney JB; Lim SY; Kovacs C; Benko E; Karandish S; Huang SH; Buzon MJ; Lichterfeld M; Irrinki A; Murry JP; Tsai A; Yu H; Geleziunas R; Trocha A; Ostrowski MA; Irvine DJ; Walker BD
    PLoS Pathog; 2016 Apr; 12(4):e1005545. PubMed ID: 27082643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Modulation of the Wnt/β-Catenin Pathway Inhibits Proliferation and Promotes Differentiation of Long-Lived Memory CD4
    Mavigner M; Zanoni M; Tharp GK; Habib J; Mattingly CR; Lichterfeld M; Nega MT; Vanderford TH; Bosinger SE; Chahroudi A
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
    Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.
    Cummins NW; Sainski-Nguyen AM; Natesampillai S; Aboulnasr F; Kaufmann S; Badley AD
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.
    Grau-Expósito J; Luque-Ballesteros L; Navarro J; Curran A; Burgos J; Ribera E; Torrella A; Planas B; Badía R; Martin-Castillo M; Fernández-Sojo J; Genescà M; Falcó V; Buzon MJ
    PLoS Pathog; 2019 Aug; 15(8):e1007991. PubMed ID: 31425551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
    Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.
    Pinzone MR; Graf E; Lynch L; McLaughlin B; Hecht FM; Connors M; Migueles SA; Hwang WT; Nunnari G; O'Doherty U
    J Virol; 2016 Dec; 90(23):10436-10445. PubMed ID: 27630237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and strategies for the eradication of the HIV reservoir.
    Kimata JT; Rice AP; Wang J
    Curr Opin Immunol; 2016 Oct; 42():65-70. PubMed ID: 27288651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.